Li Muyao, Huo Linlin, Zeng Jie, Zhu Guifen, Liu Xiangqing, Zhu Xianglong, Huang Guoming, Wang Yi, Ni Kaiyuan, Zhao Zhenghuan
College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, P. R. China.
College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, P. R. China.
Adv Healthc Mater. 2023 Feb;12(5):e2202043. doi: 10.1002/adhm.202202043. Epub 2022 Nov 24.
Photosensitizer in photodynamic therapy (PDT) accumulates in both tumor and adjacent normal tissue due to low selective biodistribution, results in undesirable side effect with limited clinic application. Herein, an intelligent nanoplatform is reported that selectively acts as reactive oxygen species (ROS) scavenger in normal tissue but as ROS generator in tumor microenvironment (TME) to differentially control ROS level in tumor and surrounding normal tissue during PDT. By down-regulating the produced ROS with dampened cytokine wave in normal tissue after PDT, the nanoplatform reduces the inflammatory response of normal tissue in PDT, minimizing the side effect and tumor metastasis in PDT. Alternatively, the nanoplatform switches from ROS scavenger to generator through the glutathione (GSH) responsive degradation in TME, which effectively improves the PDT efficacy with reduced GSH level and amplified oxidative stress in tumor. Simultaneously, the released Mn ions provide real-time and in situ signal change of magnetic resonance imaging (MRI) to monitor the reversal process of catalysis activity and achieve accurate tumor diagnosis. This TME-responsive ROS scavenger/generator with activable MRI contrast may provide a new dimension for design of next-generation PDT agents with precise diagnosis, high therapeutic efficacy, and low side effect.
光动力疗法(PDT)中的光敏剂由于生物分布选择性低,会在肿瘤组织和邻近正常组织中均有积累,导致不良副作用,限制了其临床应用。在此,报道了一种智能纳米平台,其在正常组织中选择性地作为活性氧(ROS)清除剂,但在肿瘤微环境(TME)中作为ROS生成剂,在PDT过程中差异控制肿瘤组织和周围正常组织中的ROS水平。通过在PDT后下调正常组织中产生的ROS并减弱细胞因子波动,该纳米平台降低了PDT中正常组织的炎症反应,使PDT中的副作用和肿瘤转移最小化。另外,该纳米平台通过TME中的谷胱甘肽(GSH)响应性降解从ROS清除剂转变为生成剂,随着肿瘤中GSH水平降低和氧化应激增强,有效提高了PDT疗效。同时,释放的锰离子提供磁共振成像(MRI)的实时原位信号变化,以监测催化活性的逆转过程并实现准确的肿瘤诊断。这种具有可激活MRI造影的TME响应性ROS清除剂/生成剂可为设计具有精确诊断、高治疗效果和低副作用的下一代PDT药物提供新的思路。